Get the Stockscreener App
10.44
0.05%
0.005
After Hours:
10.44
Drugs Made In America Acquisition Corp stock is traded at $10.44, with a volume of 1,145.
It is up +0.05% in the last 24 hours and up +0.38% over the past month.
Drugs Made In America Acquisition Corp is a blank check company.
See More
Previous Close:
$10.44
Open:
$10.44
24h Volume:
1,145
Relative Volume:
0.04
Market Cap:
$349.92M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.38%
6M Performance:
+1.85%
1Y Performance:
+0.00%
1-Day Range:
$10.44
$10.44
1-Week Range:
$10.43
$10.45
52-Week Range:
$9.96
$10.45
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Name
Drugs Made In America Acquisition Corp
Sector
Industry
Phone
954-870-3104
Address
2 PELICAN DR., FORT LAUDERDALE
Compare DMAA vs CCXI, LION, XXI, CCCX, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.44 | 349.75M | 0 | 0 | 0 | 0.00 |
|
CCXI
Churchill Capital Corp Xi
|
10.19 | 3.64B | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
8.09 | 2.31B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
XXI
Twenty One Capital Inc
|
6.40 | 2.01B | 0 | 0 | 0 | 0.00 |
|
CCCX
Churchill Capital Corp X
|
13.66 | 687.84M | 0 | 0 | 0 | 0.00 |
|
DMII
Drugs Made In America Acquisition Ii Corp
|
9.99 | 655.09M | 0 | 0 | 0 | 0.00 |
Drugs Made In America Acquisition Corp Stock (DMAA) Latest News
Published on: 2026-02-15 06:00:33 - mfd.ru
Published on: 2026-02-14 20:19:49 - mfd.ru
Will Innovator U.S. Equity Accelerated Plus stock beat growth indexes2025 Earnings Impact & Proven Capital Preservation Tips - mfd.ru
Earnings Miss: What analysts say about Drugs Made In America Acquisition Corp Equity Right stockJuly 2025 Rallies & Daily Momentum Trading Reports - baoquankhu1.vn
What drives Drugs Made In America Acquisition Corp.’s stock priceJuly 2025 Price Swings & AI Driven Price Forecasts - mfd.ru
Will Drugs Made In America Acquisition Corp. Equity Right benefit from sector rotation2025 Technical Overview & Expert Approved Trade Ideas - mfd.ru
Pullback Watch: Can Drugs Made In America Acquisition Corp Equity Right outperform in the next rallyQuarterly Trade Report & Daily Profit Focused Stock Screening - baoquankhu1.vn
Can Drugs Made In America Acquisition Corp. Equity Right outperform in the next rallyInsider Buying & Community Verified Trade Signals - mfd.ru
Published on: 2026-02-10 16:10:21 - mfd.ru
AI Stocks: Whats Drugs Made In America Acquisition Corps historical return2025 Dividend Review & Technical Entry and Exit Tips - baoquankhu1.vn
Layoff Tracker: Delayed Notice Reveals 141 More Layoffs From Genentech in 2025 - BioSpace
Recap Report: Is ANSCU stock influenced by commodity pricesQuarterly Market Summary & Accurate Technical Buy Alerts - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1%Here's Why - MarketBeat
Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1% – Here’s Why - Defense World
Can Drugs Made In America Acquisition Corp. navigate macro headwinds2025 Year in Review & Smart Investment Allocation Insights - mfd.ru
Quarterly Earnings: What analysts say about Drugs Made In America Acquisition Corp Equity Right stockJuly 2025 Breakouts & Safe Entry Trade Signal Reports - baoquankhu1.vn
Pfizer Inc. - Britannica
10 Best Health Care Stocks to Buy for 2026 - US News Money
Drugs Made in America Acquisition (NASDAQ:DMAAU) Stock Price Down 0% – What’s Next? - Defense World
GraniteShares 2x Long SMCI Daily ETF (NASDAQ:SMCL) Shares Up 3.7% – Still a Buy? - Defense World
Published on: 2026-02-02 18:08:46 - baoquankhu1.vn
Trade Recap: Can Drugs Made In America Acquisition Corp sustain its profitability2025 Technical Patterns & Weekly Breakout Stock Alerts - baoquankhu1.vn
Volatility Watch: What makes Drugs Made In America Acquisition Corp stock attractive today2025 Key Lessons & Advanced Swing Trade Entry Plans - baoquankhu1.vn
UPDATE: Noramco divestment continues as it re-establishes CDMO Halo Pharma - Fierce Pharma
Analyst Calls: Is Drugs Made In America Acquisition Corp Equity Right impacted by rising ratesCPI Data & Breakout Confirmation Trade Signals - baoquankhu1.vn
Pfizer CEO Albert Bourla stared down the COVID-19 pandemic. Now he has his eyes set on cancer - Fortune
Geopolitics Watch: Is HUBG attractive at current valuationEarnings Beat & Growth Focused Stock Pick Reports - baoquankhu1.vn
Aug PostEarnings: Can Drugs Made In America Acquisition Corp weather a recessionPortfolio Performance Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Energy Moves: Is Launch Two Acquisition Corp benefiting from innovation trendsTrade Ideas & Trade Opportunity Analysis - baoquankhu1.vn
Aug PreEarnings: Can Drugs Made In America Acquisition Corp weather a recessionStop Loss & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Earnings Miss: What drives Drugs Made In America Acquisition Corps stock priceJuly 2025 Selloffs & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Gains Recap: Will CINGW benefit from sector rotationQuarterly Risk Review & Safe Entry Point Alerts - baoquankhu1.vn
CEO David Burritt says U.S. Steel "absolutely" still an American company after Nippon Steel acquisition - CBS News
Wolverine Asset Management LLC Buys 227,222 Shares of Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Insider Trends: Can Drugs Made In America Acquisition Corp Equity Right grow without dilutionPortfolio Return Report & Real-Time Stock Entry Alerts - baoquankhu1.vn
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Up 0.2%Time to Buy? - MarketBeat
Buyback Watch: Will VRNT stock recover faster than market2025 Market Trends & Low Risk Growth Stock Ideas - Bộ Nội Vụ
Volume Summary: Is HIGPRG stock a defensive play in 2025Trade Exit Summary & Technical Entry and Exit Tips - Bộ Nội Vụ
Beamr Imaging (NASDAQ:BMR) Trading 4.1% Higher – Still a Buy? - Defense World
TCW Artificial Intelligence ETF (NYSEARCA:AIFD) Trading 1% Higher – What’s Next? - Defense World
Molson Coors Beverage (NYSE:TAP.A) Stock Price Up 2.2% – Time to Buy? - Defense World
Hercules Silver (OTC:BADEF) Stock Price Up 2.3% – What’s Next? - Defense World
Published on: 2026-01-10 19:03:52 - ulpravda.ru
Mid Cap Stocks To Follow Now – January 8th - Defense World
Purpose US Cash Fund ETF (TSE:PSU.U) Stock Price Up 0% – Time to Buy? - Defense World
U-BX Technology (NASDAQ:UBXG) Trading Down 1% – Time to Sell? - Defense World
Currenc Group (NASDAQ:CURR) Trading 1.2% Higher – Here’s Why - Defense World
Telecom Stocks To Watch Now – January 8th - Defense World
Drugs Made in America Acquisition (NASDAQ:DMAAU) Trading 0.2% Higher – What’s Next? - Defense World
Turning Point Brands, Inc. (NYSE:TPB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Why Spark I Acquisition Corporation stock remains undervaluedPortfolio Value Summary & Stepwise Trade Signal Implementation - Улправда
Drugs Made In America Acquisition Corp Stock (DMAA) Financials Data
There is no financial data for Drugs Made In America Acquisition Corp (DMAA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.00%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):